What are Barclays Bank's latest A-share holdings? Detailed list of Barclays Bank's equity holdings for Q1 2026.

Barclays Bank is a leading UK-based multinational financial group with deep expertise in cross-border equity investments and a long-standing strategic focus on high-quality A-share listed companies across multiple sectors. According to data from Private Fund Ranking Network—a platform tracking major institutional investors—as of April 21, 2026, Barclays Bank held stakes in over twenty A-share listed companies during Q1 2026. Its portfolio spans diverse industries including acoustic components, industrial automation, pharmaceutical distribution, optical communications, precision non-ferrous metals, food and consumer goods, oil & gas equipment, livestock farming, and electrothermal materials. Barclays Bank’s latest A-share holdings (Q1 2026): Barclays Bank’s Q1 2026 holdings include Gongda Electronics, Keyuan Smart, Luyan Pharmaceutical, LIG Photonics, Ruixin Technology, Shenke Shares, Huifa Food, Deshi Shares, Xiaoming Shares, and Rainbow Group, among others. From the Q1 2026 holdings perspective, most positions were newly initiated; some existing positions saw share increases, while only a few experienced minor reductions. Barclays Bank’s stake in any single company—expressed as a percentage of that company’s total issued share capital—remains relatively low, reflecting an overall strategy of diversified allocation. 1. Gongda Electronics Gongda Electronics specializes in R&D and manufacturing of miniature electro-acoustic components, focusing on acoustic modules and smart audio supporting products. It continuously aligns its offerings with demand from consumer electronics and smart terminal applications. During the Q1 2026 reporting period, Barclays Bank newly entered Gongda Electronics’ share register, with the corresponding market value ranking among the highest across all its holdings. 2. Keyuan Smart Keyuan Smart provides industrial automation and energy information management systems, serving细分 areas such as intelligent manufacturing, power plant operations, and smart industry—supporting digital transformation of traditional industries. Barclays Bank newly acquired shares of Keyuan Smart this quarter, signaling a strategic bet on long-term growth in industrial digitization. 3. Luyan Pharmaceutical Luyan Pharmaceutical operates across the full pharmaceutical distribution value chain—including drug wholesale, medical supply chain services, and pharmacy retail support—effectively bridging pharmaceutical manufacturers and end-user healthcare markets. As a key target in Barclays Bank’s portfolio, the institution newly entered Luyan Pharmaceutical’s circulating shares this quarter. 4. LIG Photonics LIG Photonics focuses on R&D and real-world deployment of fiber-optic sensing technologies, with applications spanning security monitoring, transportation sensing, and energy pipeline surveillance. It continues expanding its footprint in IoT-sensing-related businesses. In Q1 2026, Barclays Bank modestly increased its stake in LIG Photonics, reinforcing its exposure to this specialized optical sensing segment. 5. Ruixin Technology Ruixin Technology manufactures precision non-ferrous metal tubes and lightweight alloy components, closely aligned with downstream demand from new-energy vehicles, high-end equipment, and power transmission industries. Barclays Bank increased its holding in Ruixin Technology this quarter, continuing its strategic allocation to the premium non-ferrous processing sector. 6. Shenke Shares Shenke Shares specializes in sliding bearing manufacturing equipment, serving heavy machinery integration and transmission component markets—meeting operational requirements across industrial equipment applications. Barclays Bank significantly increased its position in Shenke Shares this quarter, while simultaneously reducing stakes in another batch of holdings, demonstrating flexible adjustments to individual stock allocations. 7. Huifa Food Huifa Food focuses on R&D and production of prepared meals and frozen foods, serving both foodservice supply chains and household consumer markets, and steadily expanding its food processing business scope.

Air Products’ Q3 FY2024 sales declined.

In fiscal year 2024’s third quarter (ended June 30), Air Products reported sales of $3.0 billion, down 2% year-on-year. Under U.S. Generally Accepted Accounting Principles (GAAP), net income totaled $709 million, up 16% year-on-year—driven primarily by favorable pricing and an improved business mix. GAAP net profit margin stood at 23.7%, an increase of 360 basis points year-on-year. For the quarter, Non-GAAP adjusted earnings per share (EPS) amounted to $3.20, up 7% year-on-year. Adjusted EBITDA totaled $1.3 billion, with an adjusted EBITDA margin of 42.4%, up 260 basis points year-on-year. Sales declined across all global regions during the quarter: • Americas: $1.2 billion, down 2% year-on-year; • Asia: $790 million, down 4% year-on-year; • Europe: $693 million, down 2% year-on-year.

Barclays Initiates Coverage of Air Products Stock at USD 353.00

12 hours ago

Barclays initiated coverage of Air Products & Chemicals with an Overweight rating and a $353 price target following Q3 2026 revenue of $3.16 billion. The company reported adjusted EPS of $3.47 despite GAAP operating losses due to project-exit charges.

ad-hoc-news.de

2026-04-14

Citi Maintains Hold Rating on Air Products and Chemicals (APD)

2026-04-21

Positive Report for Air Products and Chemicals (APD) from Berenberg Bank

2026-04-22

Air Products and Chemicals (APD) Stock Crosses Above 20-Day Moving Average

2026-04-24

Air Products Expands Core Gases Network With New Florida Facility Plan

2026-04-27

Wolfe Research raises Air Products stock price target on hydrogen demand